DEVELOPMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a big innovation in the field of biopharmaceuticals, supplying promising developments across a variety of health-related and industrial apps. With its structural similarity to Obviously derived human serum albumin, OsrHSA delivers a safer, far more responsible alternative for therapeutic use,